Works by Schuh, Andre C.


Results: 51
    1
    2
    3

    Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00668-8
    By:
    • Pratz, Keith W.;
    • Panayiotidis, Panayiotis;
    • Recher, Christian;
    • Wei, Xudong;
    • Jonas, Brian A.;
    • Montesinos, Pau;
    • Ivanov, Vladimir;
    • Schuh, Andre C.;
    • DiNardo, Courtney D.;
    • Novak, Jan;
    • Pejsa, Vlatko;
    • Stevens, Don;
    • Yeh, Su-Peng;
    • Kim, Inho;
    • Turgut, Mehmet;
    • Fracchiolla, Nicola;
    • Yamamoto, Kazuhito;
    • Ofran, Yishai;
    • Wei, Andrew H.;
    • Bui, Cat N.
    Publication type:
    Article
    4
    5
    6
    7
    8

    A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 10, p. 2793, doi. 10.3109/10428194.2015.1018248
    By:
    • How, Jonathan;
    • Minden, Mark D.;
    • Brian, Leber;
    • Chen, Eric X.;
    • Brandwein, Joseph;
    • Schuh, Andre C.;
    • Schimmer, Aaron D.;
    • Gupta, Vikas;
    • Webster, Sheila;
    • Degelder, Tammy;
    • Haines, Patricia;
    • Stayner, Lee-Anne;
    • McGill, Shauna;
    • Wang, Lisa;
    • Piekarz, Richard;
    • Wong, Tracy;
    • Siu, Lillian L.;
    • Espinoza-Delgado, Igor;
    • Holleran, Julianne L.;
    • Egorin, Merrill J.
    Publication type:
    Article
    9
    10
    11

    Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 363, doi. 10.1002/ajh.23640
    By:
    • Minden, Mark D.;
    • Hogge, Donna E.;
    • Weir, Scott J.;
    • Kasper, Jim;
    • Webster, Debra A.;
    • Patton, Lavonne;
    • Jitkova, Yulia;
    • Hurren, Rose;
    • Gronda, Marcela;
    • Goard, Carolyn A.;
    • Rajewski, Lian G.;
    • Haslam, John L.;
    • Heppert, Kathleen E.;
    • Schorno, Kevin;
    • Chang, Hong;
    • Brandwein, Joseph M.;
    • Gupta, Vikas;
    • Schuh, Andre C.;
    • Trudel, Suzanne;
    • Yee, Karen W. L.
    Publication type:
    Article
    12
    13

    Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01263-3
    By:
    • Pullarkat, Vinod;
    • Pratz, Keith W.;
    • Döhner, Hartmut;
    • Recher, Christian;
    • Thirman, Michael J.;
    • DiNardo, Courtney D.;
    • Fenaux, Pierre;
    • Schuh, Andre C.;
    • Wei, Andrew H.;
    • Pigneux, Arnaud;
    • Jang, Jun-Ho;
    • Juliusson, Gunnar;
    • Miyazaki, Yasushi;
    • Selleslag, Dominik;
    • Arellano, Martha L.;
    • Liu, Chenglong;
    • Ridgeway, Jean A.;
    • Potluri, Jalaja;
    • Schuler, Jovita;
    • Konopleva, Marina
    Publication type:
    Article
    14
    15
    16

    Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S217, doi. 10.1016/j.clml.2019.07.090
    By:
    • DiNardo, Courtney D.;
    • Stein, Anthony S.;
    • Stein, Eytan M.;
    • Fathi, Amir T.;
    • Frankfurt, Olga;
    • Schuh, Andre C.;
    • Döhner, Hartmut;
    • Martinelli, Giovanni;
    • Raffoux, Emmanuel;
    • Tan, Peter;
    • Zeidan, Amer;
    • de Botton, Stéphane;
    • Kantarjian, Hagop M.;
    • Stone, Richard M.;
    • Lam, Du;
    • Wang, Xiwei;
    • Gong, Jing;
    • Kapsalis, Stephanie M.;
    • Hickman, Denice;
    • Zhang, Vickie
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.

    Published in:
    Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2329027
    By:
    • Perusini, Maria Agustina;
    • Andrews, Claire;
    • Atenafu, Eshetu G.;
    • Gupta, Vikas;
    • Maze, Dawn;
    • Schuh, Andre C.;
    • Yee, Karen WL.;
    • Bankar, Aniket;
    • Davidson, Marta B.;
    • Richard-Carpentier, Guillaume;
    • Chan, Steven M.;
    • Sibai, Jad;
    • Schimmer, Aaron D.;
    • Minden, Mark D.;
    • Sibai, Hassan
    Publication type:
    Article
    26
    27
    28

    Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.

    Published in:
    Nature, 2014, v. 508, n. 7496, p. 420, doi. 10.1038/nature13190
    By:
    • Shlush, Liran I.;
    • Zandi, Sasan;
    • Mitchell, Amanda;
    • Chen, Weihsu Claire;
    • Brandwein, Joseph M.;
    • Gupta, Vikas;
    • Kennedy, James A.;
    • Schimmer, Aaron D.;
    • Schuh, Andre C.;
    • Yee, Karen W.;
    • McLeod, Jessica L.;
    • Doedens, Monica;
    • Medeiros, Jessie J. F.;
    • Marke, Rene;
    • Kim, Hyeoung Joon;
    • Lee, Kwon;
    • McPherson, John D.;
    • Hudson, Thomas J.;
    • Pan-Leukemia Gene Panel Consortium, The HALT;
    • Brown, Andrew M. K.
    Publication type:
    Article
    29

    Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.

    Published in:
    Nature, 2014, v. 506, n. 7488, p. 328, doi. 10.1038/nature13038
    By:
    • Shlush, Liran I.;
    • Zandi, Sasan;
    • Mitchell, Amanda;
    • Chen, Weihsu Claire;
    • Brandwein, Joseph M.;
    • Gupta, Vikas;
    • Kennedy, James A.;
    • Schimmer, Aaron D.;
    • Schuh, Andre C.;
    • Yee, Karen W.;
    • McLeod, Jessica L.;
    • Doedens, Monica;
    • Medeiros, Jessie J. F.;
    • Marke, Rene;
    • Kim, Hyeoung Joon;
    • Lee, Kwon;
    • McPherson, John D.;
    • Hudson, Thomas J.;
    • Pan-Leukemia Gene Panel Consortium, The HALT;
    • Brown, Andrew M. K.
    Publication type:
    Article
    30
    31
    32

    Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 4, p. 1187, doi. 10.1007/s00277-024-05639-6
    By:
    • Lucero, Josephine;
    • Alhumaid, Muhned;
    • Novitzky-Basso, Igor;
    • Capo-Chichi, Jose-Mario;
    • Stockley, Tracy;
    • Gupta, Vikas;
    • Bankar, Aniket;
    • Chan, Steven;
    • Schuh, Andre C.;
    • Minden, Mark;
    • Mattsson, Jonas;
    • Kumar, Rajat;
    • Sibai, Hassan;
    • Tierens, Anne;
    • Kim, Dennis D. H.
    Publication type:
    Article
    33
    34

    A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 3, p. 384, doi. 10.1111/bjh.13146
    By:
    • Kuo, Kevin H. M.;
    • Callum, Jeannie L.;
    • Panzarella, Tony;
    • Jacks, Lindsay M.;
    • Brandwein, Joseph;
    • Crump, Michael;
    • Curtis, John E.;
    • Gupta, Vikas;
    • Lipton, Jeffrey H.;
    • Minden, Mark D.;
    • Sher, Graham D.;
    • Schimmer, Aaron D.;
    • Schuh, Andre C.;
    • Yee, Karen W. L.;
    • Keating, Armand;
    • Messner, Hans A.
    Publication type:
    Article
    35
    36
    37
    38

    Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.

    Published in:
    International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 415, doi. 10.3390/ijms18020415
    By:
    • Pleyer, Lisa;
    • Döhner, Hartmut;
    • Dombret, Hervé;
    • Seymour, John F.;
    • Schuh, Andre C.;
    • Beach, C. L.;
    • Swern, Arlene S.;
    • Burgstaller, Sonja;
    • Stauder, Reinhard;
    • Girschikofsky, Michael;
    • Sill, Heinz;
    • Schlick, Konstantin;
    • Thaler, Josef;
    • Halter, Britta;
    • Spandl, Sigrid Machherndl;
    • Zebisch, Armin;
    • Pichler, Angelika;
    • Pfeilstöcker, Michael;
    • Autzinger, Eva M.;
    • Lang, Alois
    Publication type:
    Article
    39
    40
    41
    42

    Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.

    Published in:
    2017
    By:
    • Seymour, John F.;
    • Döhner, Hartmut;
    • Butrym, Aleksandra;
    • Wierzbowska, Agnieszka;
    • Selleslag, Dominik;
    • Jun Ho Jang;
    • Kumar, Rajat;
    • Cavenagh, James;
    • Schuh, Andre C.;
    • Candoni, Anna;
    • Récher, Christian;
    • Sandhu, Irwindeep;
    • del Castillo, Teresa Bernal;
    • Al-Ali, Haifa Kathrin;
    • Falantes, Jose;
    • Stone, Richard M.;
    • Minden, Mark D.;
    • Weaver, Jerry;
    • Songer, Steve;
    • Beach, C. L.
    Publication type:
    journal article
    43
    44
    45
    46
    47
    48
    49
    50